fda import alert semaglutide green list glp-1 tirzepatide 2025 SFDA updates guidelines for pharmaceutical variation requirements FDA Import Alert 66-80: GLP-1 – FDA approval is a milestone,

Individuals Seeking Telehealth Convenience: For those who prefer remote consultations and home delivery, Remedy Meds is a convenient choice

However, you may decide to get your labs completed elsewhere

Inflammatory versus neoplastic, mucinous versus non-mucinous, and duct communication remain the core branch points before surveillance or EUS-FNA is planned

Instead, it depends on the freedom to explore, to fail, and to follow evidence wherever it leads, because that is where the most transformative breakthroughs are often found

Joseph Zucchi, PA-C, MPAS, is a board-certified physician associate specializing in obesity medicine and clinical supervisor at Transition Medical Weight Loss in Salem, New Hampshire

Follow your healthcare provider's guidance